and BMS has said it remains committed to developing it for IBD. It is hoping that a phase 2 trial in ulcerative colitis called IM011-127, which is using a higher dose of the drug and is due to ...
Researchers conducted a retrospective study to assess the diagnostic value of anti-CdtB and anti-vinculin antibodies in people with inflammatory bowel disease (IBD) who have persistent ...